Integration of class I HDAC inhibitors into current treatments for prostate cancer.

Activity: Talk or presentation types › Oral presentation

Period25 Aug 2019
Event titleFEBS Advanced Lecture Course: Epigenetic, nuclear receptors and disease.
Event typeWorkshop
LocationGreeceShow on map
Degree of RecognitionInternational